CombiMatrix Signs Contract With Stratose Networks Division, One of the Largest Directly-Managed PPO Networks in U.S.

IRVINE, Calif., July 22, 2014 (GLOBE NEWSWIRE) — CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company specializing in DNA-based testing services for developmental disorders and cancer diagnostics, today announced that it has entered into a contractual agreement with Stratose for coverage of CombiMatrix’s diagnostic laboratory services.